Cochrane Abstracts
Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mesenchymal Stem Cells for the Prevention and Treatment of Bronchopulmonary Dysplasia in Preterm Infants." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435364/all/Mesenchymal_stem_cells_for_the_prevention_and_treatment_of_bronchopulmonary_dysplasia_in_preterm_infants.
Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435364/all/Mesenchymal_stem_cells_for_the_prevention_and_treatment_of_bronchopulmonary_dysplasia_in_preterm_infants. Accessed December 2, 2024.
Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435364/all/Mesenchymal_stem_cells_for_the_prevention_and_treatment_of_bronchopulmonary_dysplasia_in_preterm_infants
Mesenchymal Stem Cells for the Prevention and Treatment of Bronchopulmonary Dysplasia in Preterm Infants [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435364/all/Mesenchymal_stem_cells_for_the_prevention_and_treatment_of_bronchopulmonary_dysplasia_in_preterm_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants
ID - 435364
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435364/all/Mesenchymal_stem_cells_for_the_prevention_and_treatment_of_bronchopulmonary_dysplasia_in_preterm_infants
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
